Strategic Collaboration Ozgene is actively expanding partnerships in the neuroscience and rare disease spaces, evidenced by recent CureSHANK and Innoser collaborations to enable Shank3 cKO mouse models. This signals a receptive market for joint development programs and co-marketing opportunities to reach researchers focused on neurogenetics and behavioral studies.

Global CRO Capabilities With end-to-end genetically modified mouse model services spanning design, phenotyping, genotyping and custom breeding across the US and Australia, Ozgene offers scalable, compliant solutions (AAALAC-accredited facilities) suitable for large, multi-site pharmaceutical and academic programs seeking reliable model supply and vivarium management.

Innovative Technology GoGermline and OzBIG platforms position Ozgene as a tech-forward CRO capable of faster timelines and complex genome edits, enabling clients to reduce animal usage and accelerate preclinical workflows, which aligns with sponsors prioritizing 3Rs compliance and efficiency.

Distributor Access As an authorized JAX distributor in Australia, New Zealand, and Indonesia, Ozgene can facilitate local access to high-quality stock mice and rats, suggesting cross-border sales opportunities for regional distributors and collaborations with EU/US partners seeking regional supply certainty.

Financial and Market Signals Revenue in the mid-range of tens of millions and a 25+ year track record indicate financial stability and mature operations, bolstering confidence for enterprise deals, longer contract engagements, and scalable model supply agreements with pharma, biotech, and academic customers.